Thalidomide bulk supplier for pharma manufacturers

Thalidomide Suppliers & Bulk Manufacturers

Available Forms: Capsules

Available Strengths: 50 mg, 100 mg, 150 mg , 200 mg

Reference Brands: Thalomid®(US), Thalidomide Celgene(EU)

halidomide is an oral immunomodulatory drug approved for multiple myeloma and erythema nodosum leprosum (ENL) in the US and EU. Available as Thalomid® in the US and Thalidomide Celgene in the EU, it comes in 50 mg, 100 mg, 150 mg, and 200 mg capsules. Known for its anti-angiogenic properties, it’s used in combination therapy for oncology. Due to teratogenic risks, distribution is regulated. Ideal for B2B pharma seeking oncology portfolio expansion, licensing, or API sourcing in global markets.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: Thalidomide is an oral immunomodulatory drug (IMiD) approved in the US and EU for treating multiple myeloma and erythema nodosum leprosum (ENL). Marketed as Thalomid® in the US and Thalidomide Celgene in the EU, it is available in 50 mg, 100 mg, 150 mg, and 200 mg capsule strengths. With anti-angiogenic and anti-inflammatory properties, thalidomide is a key oncology asset in combination therapy. Due to its teratogenic risks, distribution is strictly regulated under REMS and controlled access programs. Ideal for B2B pharmaceutical companies seeking oncology portfolio expansion, licensing, or GMP-compliant API and finished formulation sourcing in global markets.

Thalidomide — third party manufacturing & bulk supply

Thalidomide is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Thalidomide is supplied as Capsules — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Thalidomide listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Thalidomide →

Back to Listing

Frequently Asked Questions

Thalidomide is listed as Capsules in 50 mg, 100 mg, 150 mg , 200 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Thalidomide is referenced against Thalomid®(US), Thalidomide Celgene(EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.